U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06930235) titled 'Effectiveness of Midodrine as an Adjuvant to Norepinephrine in Weaning Critically Ill Patients From Vasopressors' on April 08.
Brief Summary: This study aims to evaluate the effectiveness of midodrine as an adjuvant to norepinephrine in weaning critically ill patients from vasopressors
Study Start Date: March 13
Study Type: INTERVENTIONAL
Condition:
Shock
Intervention:
DRUG: Weaning critically ill patients from norepinephrine using midodrine as an adjuvant to norepinephrine
* Patients in group I will receive midodrine (10 mg orally every 8 hours) in addition to administered concurrently with ongoing intravenous norepinephrin...